SuperGen (SUPG) Announces Departure of Chief Medical Officer
SuperGen, Inc. (NASDAQ: SUPG) announced that Gregory Berk, M.D., Chief Medical Officer, has left the Company.
Michael D. Young, M.D., Ph.D., a current member of the SuperGen board of directors and Chairman and Chief Scientific Officer of Strategic Healthcare Development, LLC, will serve as SuperGen’s interim Chief Medical Advisor, consulting to James S. J. Manuso, Ph.D., President and Chief Executive Officer.
Dr. Manuso will oversee both clinical and regulatory development until a replacement for Dr. Berk can be found. A global search for a new chief medical officer has been initiated. [SM]
Michael D. Young, M.D., Ph.D., a current member of the SuperGen board of directors and Chairman and Chief Scientific Officer of Strategic Healthcare Development, LLC, will serve as SuperGen’s interim Chief Medical Advisor, consulting to James S. J. Manuso, Ph.D., President and Chief Executive Officer.
Dr. Manuso will oversee both clinical and regulatory development until a replacement for Dr. Berk can be found. A global search for a new chief medical officer has been initiated. [SM]
You May Also Be Interested In
- Edelman Financial (EF) Says Ric Edelman Becomes Sole CEO; Ball Remains Chairman
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- Southern Co. (SO) Appoints Mark Crosswhite as COO; Makes Other Exec Moves
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
